Bharat Rasayan Limited
Valuation (77/100) does the heavy lifting; momentum (6/100) is the drag.
Buy zoneOur blended model reads Bharat Rasayan Limited as a Hold at 59/100. We put fair value near ₹1,493.45; at ₹1,280.3 that leaves roughly 17% upside, so the stock screens undervalued by 17%. On 3.6x trailing earnings it sits cheaper than the Basic Materials median of about 22.2x. The price is about 56% below its 52-week high of ₹2,942 and 6% above the low of ₹1,210.1. Financial health scores 100/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 5/9. It clears 7 of 13 investability checks, with durability 69, valuation 76 and momentum 6 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹1,194.76.
1-year price
EOD · 2026-07-3152-week range
-56.48% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Hold59Piotroski F-score 5/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Fail: ROE above 15%: 12.1%
- Pass: Low debt (D/E < 0.5): 0.00x
- Pass: Positive free cash flow
- Fail: Revenue growth > 10%: 1%
- Pass: Earnings growing: 52%
- Pass: Net margin ≥ 10%: 11.7%
- Pass: Current ratio > 1.5: 7.78
- Pass: Below our fair value
- Fail: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Fail: Above 50-day average
- No data: Positive 1-year return
- Pass: Altman Z in safe zone: Z 10.69
- Fail: Piotroski ≥ 7: 5/9
Quarterly results
Annual financials
Shareholding
- Promoter0.0%
- Institutions2.3%
- Public & other97.7%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Lightly leveraged balance sheet.
- Financially solid — Altman Z 10.69.
Opportunities
- Earnings growing (52% YoY).
- Trading in our value buy zone versus sector peers.
- Well off its 52-week high — possible mean-reversion.
Bear case
Weaknesses
- Price below its 200-day moving average (downtrend).
About Bharat Rasayan Limited
Bharat Rasayan Limited manufactures and sells technical grade pesticides and chemical intermediates in India, producing insecticides, herbicides, and fungicides. The company distributes its products domestically and internationally through multinational agrochemical companies and traders.
Bharat Rasayan Limited — frequently asked questions
Is Bharat Rasayan Limited a buy, hold or sell?
StocksWizard currently rates Bharat Rasayan Limited (BHARATRAS) a Hold, based on a blended score of 59/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Bharat Rasayan Limited's fair value?
Our blended DCF and relative-valuation model estimates Bharat Rasayan Limited's fair value at about ₹1,493.45, versus a current price of ₹1,280.3 — roughly 17% upside. On that basis the stock looks undervalued by 17%.
Is Bharat Rasayan Limited financially healthy?
Bharat Rasayan Limited scores 100/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 5/9.
How has Bharat Rasayan Limited's share price performed?
Bharat Rasayan Limited is down 7% over three months, and last traded at ₹1,280.3. Past performance doesn't predict future returns.
More in Basic Materials
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.